| Closing Price ($) | Shares Out (MM) | Market Cap ($MM) |
| $0.00 | 0 | $0 |
| 10-Q | 2019-09-30 | Quarter: 2019-09-30 |
| 10-Q | 2019-06-30 | Quarter: 2019-06-30 |
| S-1 | 2019-06-28 | Public Filing |
| 8-K | 2019-11-06 | Earnings, Exhibits |
| 8-K | 2019-10-07 | Regulation FD, Exhibits |
| 8-K | 2019-09-05 | Earnings, Regulation FD, Exhibits |
| Comparables ($'000) | Ticker | Market Cap | Assets | Liabilities | Revenue | Gross Profit | Net Income | EBITDA | EV |
| Ryanair Holdings | RYAA | -0 | 13,250,700 | 8,035,800 | -0 | -0 | -0 | -0 | -34,900 |
| Lingo Media | LMDC | -0 | 1,534 | 980 | -0 | -0 | -0 | -0 | -0 |
| Apollo Education | APOL | 1,063,295 | 1,955,243 | 886,324 | -0 | -0 | 4,070 | 36,602 | 579,272 |
| China Crawfish | CACA | -0 | 11 | 6 | 0 | -0 | -6 | -6 | -5 |
| Mirenco | MREO | ||||||||
| Granite Real Estate | GRP | ||||||||
| Weyland Tech | WEYL | -0 | 5,401 | -1,823 | -0 | 1,068 | 768 | 831 | -949 |
| Baynon | BNON | -0 | 20 | -85 | 0 | 0 | -6 | -6 | -20 |
| Green Planet Bio Engineering | GPLB | 3,001 | 0 | 272 | -0 | -0 | -6 | -6 | 3,001 |
| G-Mes Holdings | GMES | -0 | 1,149 | 1,164 | 341 | 293 | 39 | 78 | 137 |
| Immune Therapeutics | IMUN | 0 | 24 | 12,553 | 0 | 0 | -825 | -824 | -21 |
| Therapeutic Solutions | TSOI | 0 | 367 | -1,851 | 9 | 8 | -228 | -125 | 481 |
| Blue Sphere | BLSP | -0 | 40,921 | 75,883 | -0 | 536 | -5,854 | -5,860 | 7,266 |
| Frontier Digital Media Group | FDMG | -0 | 10 | 25 | 2 | -0 | -1 | -1 | -9 |
| Stem Holdings | STEMH | -0 | 10,694 | 2,390 | 310 | -0 | -908 | -908 | -782 |
| MWF Global | MWF | -0 | -0 | -0 | 0 | -0 | -8 | -8 | -1 |
| Clean Coal Technologies | CCTC | -0 | 1 | 25,459 | -0 | -0 | 22,154 | 23,009 | -1 |
| SpringWorks | SWTX | ||||||||
| Brighthouse Life Insurance Co of Ny | BHNY | -0 | 7,633,046 | 6,936,313 | -0 | -0 | -0 | -0 | -18,583 |
| Imine | JRVS | 5,585 | 2 | 590 | -0 | -0 | -257 | -257 | 6,083 |
| Balance Sheet ($'000) | 2019-06-30 |
| Cash | 39,023 |
| Accounts Receivable | 35,086 |
| Inventory | 13,835 |
| PP&E | 10,792 |
| Assets | 177,209 |
| Accounts Payable | 8,975 |
| Long-Term Debt | |
| Liabilities | 49,667 |
| Stockholders' Equity | -109,470 |
| Income Statement ($'000) | 2019-06-30 |
| Revenue | 40,886 |
| Cost of Revenue | 12,883 |
| Gross Profit | 28,003 |
| R&D | 10,291 |
| SG&A | 31,854 |
| Tax | 5 |
| Net Income | -14,244 |
| Cash Flow ($'000) | 2019-06-30 |
| Cash Operating | |
| Cash Investing | |
| Cash Financing |